Login to Your Account



China Biologic increases stake in Guizhou Taibang for $87.1M

By Shannon Ellis
Staff Writer

Wednesday, August 27, 2014

SHANGHAI – China Biologic Inc., of Beijing, has topped up its controlling equity interest by 20 percent in Guizhou Taibang Biological Products Co. Ltd., in a deal valued at $87.1 million.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription